General Information of the Compound
| Compound ID |
CP0415105
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-ethyl-3-[4-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-propylphenoxy]butyl]imidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H32F6N2O6
|
||||||||||||||||||
| Molecular Weight |
618.571
|
||||||||||||||||||
| Canonical SMILES |
CCCc1cc(ccc1OCCCCN1C(=O)NC(CC)(C1=O)c1ccc2OCCOc2c1)C(O)(C(F)(F)F)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H32F6N2O6/c1-3-7-18-16-20(27(40,28(30,31)32)29(33,34)35)9-10-21(18)41-13-6-5-12-37-24(38)26(4-2,36-25(37)39)19-8-11-22-23(17-19)43-15-14-42-22/h8-11,16-17,40H,3-7,12-15H2,1-2H3,(H,36,39)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZVBBQBPDJQNSCO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01555, Oxysterols receptor LXR-alpha
Protein ID: PT01887, Oxysterols receptor LXR-beta